
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Franz B. Humer, chairman of the board of directors of the Roche Group, will not stand for re-election to the Board in 2014.
Franz B. Humer, chairman of the board of directors of the Roche Group, announced at the company’s March 5 annual general meeting that he will not stand for re-election to the Board in 2014. The company will nominate a successor for the chairmanship in autumn 2013.
The Roche Board has decided that Humer’s successor will also serve as non-executive Chairman, thus maintaining the established separation of the offices of Chairman and Chief Executive Officer, according to






